Particularly, compound 2 exhibited better antimicrobial activity against the largest number of assayed microorganisms.Conclusion: Further modification and development of o-benzenedisulfonimido-sulfonamide derivatives and additional in vitro studies against putative targets may result in new antimicrobial drug candidates in the near future.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Background and Aims: The discovery of new antimicrobials to overcome antimicrobial resistance has always been an important topic for sustainable world health.
📊
Temel Bulgular & Veri:Since the sulfonamide carrying heterocyclic compounds present a number of advantages as biologically active compounds, in our work reported herein, a small collection of previously synthesized o-benzenedisulfonimido-sulfonamide derivatives were assayed to determine antimicrobial profiles against ten different microorganisms in search of finding promising new antibacterial/antifungal agents.Methods: Eight compounds and their standards were tested against seven bacterial and three fungal strains, including members of Gram-positive, Gram-negative bacteria, and Candida spp., using the microbroth dilution method to measure their MIC (minimum inhibitory concentration) values.Results: All assayed molecules showed different inhibitory effects on ten different targets, with considerable MIC values.
💡
Sonuç & Katkı:Particularly, compound 2 exhibited better antimicrobial activity against the largest number of assayed microorganisms.Conclusion: Further modification and development of o-benzenedisulfonimido-sulfonamide derivatives and additional in vitro studies against putative targets may result in new antimicrobial drug candidates in the near future.
Background and Aims: The discovery of new antimicrobials to overcome antimicrobial resistance has always been an important topic for sustainable world health. Since the sulfonamide carrying heterocyclic compounds present a number of advantages as biologically active compounds, in our work reported herein, a small collection of previously synthesized o-benzenedisulfonimido-sulfonamide derivatives were assayed to determine antimicrobial profiles against ten different microorganisms in search of finding promising new antibacterial/antifungal agents.Methods: Eight compounds and their standards were tested against seven bacterial and three fungal strains, including members of Gram-positive, Gram-negative bacteria, and Candida spp., using the microbroth dilution method to measure their MIC (minimum inhibitory concentration) values.Results: All assayed molecules showed different inhibitory effects on ten different targets, with considerable MIC values. Particularly, compound 2 exhibited better antimicrobial activity against the largest number of assayed microorganisms.Conclusion: Further modification and development of o-benzenedisulfonimido-sulfonamide derivatives and additional in vitro studies against putative targets may result in new antimicrobial drug candidates in the near future.
DEMİR-YAZICI, K., YILMAZ, F. N., ÇELİK, B. Ö., AKDEMİR, Ö. G. (2022). Evaluation of some o-benzenedisulfonimido– sulfonamide derivatives as potent antimicrobial agents. İstanbul Journal of Pharmacy, Cilt: 3 - Sayı: 52, 297–301. https://ajindex.com/articles/876887
Abdel-Aziz, A. A. M., El-Azab, A. S., AlSaif, N. A., Alanazi, M. M., El- Gendy, M. A., Obaidullah, A. J Al-Suwaidan, I. A. (2020). Synthe- sis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activi- ties of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: A molecular docking study. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 610-621. https:// doi.org/10.1080/14756366.2020.1722120 Alaa, A. M., El-Azab, A. S., Attia, S. M., Al-Obaid, A. M., Al-Omar, M. A., & El-Subbagh, H. I. (2011). Synthesis and biological evaluation of some novel cyclic-imides as hypoglycaemic, anti-hyperlipid- emic agents. European Journal of Medicinal Chemistry, 46(9), 4324- 4329. https://doi.org/10.1016/j.ejmech.2011.07.002
Angeli, A., Pinteala, M., Maier, S. S., Toti, A., Mannelli, L. D. C., Ghe- lardini, C. Supuran, C. T. (2021). Tellurides bearing benzensul- fonamide as carbonic anhydrase inhibitors with potent antitu- mor activity. Bioorganic & Medicinal Chemistry Letters, 45, 128147. https://doi.org/10.1016/j.bmcl.2021.128147
Apaydın, S., &Török, M. (2019). Sulfonamide derivatives as multi- target agents for complex diseases. Bioorganic & Medicinal Chemistry Letters, 29(16), 2042-2050. https://doi.org/10.1016/j. bmcl.2019.06.041 Azevedo-Barbosa, H., Dias, D. F., Franco, L. L., Hawkes, J. A., &Carv- alho, D. T. (2020). From antibacterial to antitumour agents: A brief review on the chemical and medicinal aspects of sulfonamides. Mini Reviews in Medicinal Chemistry, 20(19), 2052-2066. https://doi. org/10.2174/1389557520666200905125738 Banarouei, N., Davood, A., Shafaroodi, H., Saeedi, G., &Shafiee, A. (2019). N-arylmethylideneaminophthalimide: Design, synthesis and evaluation as analgesic and anti-inflammatory agents. Mini Reviews in Medicinal Chemistry, 19(8),679-687. https://doi.org/10.2 174/1389557518666180424101009 Bermingham, A., & Derrick, J. P. (2002). The folic acid biosynthe- sis pathway in bacteria: Evaluation of potential for antibacterial drug discovery.Bioessays, 24(7), 637-648. https://doi.org/10.1002/ bies.10114 Capasso, C., &Supuran, C. T. (2014). Sulfa and trimethoprim-like drugs–Antimetabolites acting as carbonic anhydrase, dihydrop- teroate synthase and dihydrofolate reductase inhibitors. Jour- nal of Enzyme Inhibition and Medicinal Chemistry, 29(3), 379-387. https://doi.org/10.3109/14756366.2013.787422
Chen, H., Wang, B., Li, P., Yan, H., Li, G., Huang, H., & Lu, Y. (2021). The optimization and characterizati